CJC-1295 W/DAC
Long-Acting GHRH
Best For
Convenience protocols, sustained GH support, anti-aging
8+ days
Half-life of CJC-1295 W/DAC
1-2x
Weekly dosing frequency
Albumin
DAC binds albumin for extended circulation
How It Works
CJC-1295 with Drug Affinity Complex (DAC) is a GHRH analogue engineered for extended half-life. The DAC modification allows it to bind albumin in the bloodstream, extending its active life to 8+ days. This provides sustained, elevated GH and IGF-1 levels with minimal dosing frequency — typically once or twice weekly.
Key Research Areas
Extended Half-Life
8+ day half-life — once or twice weekly dosing
Sustained GH Elevation
Continuous GH and IGF-1 support between doses
Convenience
Fewest injections of any GH-releasing peptide
Anti-Aging
Sustained IGF-1 elevation supports tissue maintenance
Research Highlights
- 8+ day half-life — sustained GH and IGF-1 elevation
- Most convenient GH-releasing peptide — once or twice weekly
Formulation Notes
Common concentrations referenced in published clinical studies:
[DP-7005]5mgCategory
CJC-1295 combined with Ipamorelin creates GHRH + GHRP synergy producing up to 10x the growth hormone output of either pe...
Explore Amplify category →Educational Content. This compound profile is for informational purposes only. Not intended as medical advice, diagnosis, or treatment.
Related Compounds
CJC-1295 WO/DAC
Short-Acting GHRH
- Mimics body's natural 30-minute GH pulse pattern
- Ideal stacking partner for Ipamorelin — synergistic release
Reference Codes
[DP-7105]5mgCJC-1295 + Ipamorelin
GHRH + GHRP Combination
- Pre-combined GHRH + GHRP for maximum GH synergy
- Clean signal — no cortisol or prolactin elevation
Reference Codes
[DP-7210]10mg (5+5)Ipamorelin
Clean GH Secretagogue
- Selective GH release with no cortisol or prolactin elevation
- Ideal for stacking with GHRH analogues for synergistic pulses
Reference Codes
[EL-1110]10mg